Garcia-Planella E - Search Results

1

Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project.

González-Muñoza C, Calafat M, Gisbert JP, Iglesias E, Mínguez M, Sicilia B, Aceituno M, Gomollón F, Calvet X, Ricart E, De Castro L, Rivero M, Mesonero F, Márquez L, Nos P, Rodríguez-Pescador A, Guardiola J, García-Sepulcre M, García-López S, Lorente-Poyatos RH, Alba C, Sánchez-Ocaña R, Vera I, Madero L, Riestra S, Navarro-Llavat M, Pérez-Calle JL, Camps B, Van Domselaar M, Lucendo AJ, Martín-Arranz MD, Montoro-Huguet MA, Sierra-Ausín M, Llaó J, Carpio D, Varela P, Merino O, Fernández-Salazar LI, Piqueras M, Sesé E, Busquets D, Tardillo C, Maroto N, Riera J, Martínez-Flores C, Muñoz F, Gordillo-Ábalos J, Bertoletti F, Garcia-Planella E, Domènech E; ENEIDA project of GETECCU. González-Muñoza C, et al. Among authors: garcia planella e. Postgrad Med J. 2024 Oct 18;100(1189):836-844. doi: 10.1093/postmj/qgae076. Postgrad Med J. 2024. PMID: 38913019

2

[Intravenous cyclosporine A in the treatment of refractory Crohn's disease].

García-Planella E, Domènech E, Cabré E, Bernal MI, Gassull MA. García-Planella E, et al. Med Clin (Barc). 2002 Nov 9;119(16):610-2. doi: 10.1016/s0025-7753(02)73514-8. Med Clin (Barc). 2002. PMID: 12433336 Spanish.

3

Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFalpha antibodies (infliximab).

Garcia-Planella E, Domènech E, Esteve-Comas M, Bernal I, Cabré E, Boix J, Gassull MA. Garcia-Planella E, et al. Eur J Gastroenterol Hepatol. 2003 Apr;15(4):351-4. doi: 10.1097/00042737-200304000-00003. Eur J Gastroenterol Hepatol. 2003. PMID: 12655253

4

6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine.

Domènech E, Nos P, Papo M, López-San Román A, Garcia-Planella E, Gassull MA. Domènech E, et al. Scand J Gastroenterol. 2005 Jan;40(1):52-5. doi: 10.1080/00365520410009492. Scand J Gastroenterol. 2005. PMID: 15841714

5

Predictors of clinical response to systemic steroids in active ulcerative colitis.

Bernal I, Mañosa M, Domènech E, Garcia-Planella E, Navarro M, Lorenzo-Zúñiga V, Cabré E, Gassull MA. Bernal I, et al. Dig Dis Sci. 2006 Aug;51(8):1434-8. doi: 10.1007/s10620-006-9103-7. Epub 2006 Jul 26. Dig Dis Sci. 2006. PMID: 16868820

6

Medication-taking behavior in a cohort of patients with inflammatory bowel disease.

Bernal I, Domènech E, Garcia-Planella E, Marín L, Mañosa M, Navarro M, Cabré E, Gassull MA. Bernal I, et al. Dig Dis Sci. 2006 Dec;51(12):2165-9. doi: 10.1007/s10620-006-9444-2. Epub 2006 Nov 4. Dig Dis Sci. 2006. PMID: 17086434

7

[Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease].

García-Planella E, Marín L, Domènech E, Bernal I, Mañosa M, Zabana Y, Gassull MA. García-Planella E, et al. Med Clin (Barc). 2007 Jan 20;128(2):45-8. doi: 10.1157/13097468. Med Clin (Barc). 2007. PMID: 17266900 Spanish.

8

Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.

Cantó E, Ricart E, Busquets D, Monfort D, García-Planella E, González D, Balanzó J, Rodriguez-Sanchez JL, Vidal S. Cantó E, et al. World J Gastroenterol. 2007 Nov 7;13(41):5446-53. doi: 10.3748/wjg.v13.i41.5446. World J Gastroenterol. 2007. PMID: 17907287 Free PMC article.

9

Pernicious anaemia in triplets. A case report and literature review.

Masnou H, Domènech E, Navarro-Llavat M, Zabana Y, Mañosa M, García-Planella E, Gassull MA. Masnou H, et al. Gastroenterol Hepatol. 2007 Dec;30(10):580-2. doi: 10.1157/13112591. Gastroenterol Hepatol. 2007. PMID: 18028852 Review.

10

Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine and validation in an independent cohort.

Aceituno M, García-Planella E, Heredia C, Zabana Y, Feu F, Domènech E, Gassull MA, Panés J. Aceituno M, et al. Inflamm Bowel Dis. 2008 Mar;14(3):347-52. doi: 10.1002/ibd.20322. Inflamm Bowel Dis. 2008. PMID: 18050296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters